PureTech Health’s fully human anti-galectin-9 IgG4 monoclonal antibody was granted FDA orphan status as a treatment of Acute Myeloid Leukemia, according to a post to the agency’s website.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>